Cohere Acquires Reliant AI to Expand Sovereign Enterprise AI for the Global Biopharma ...
PushButton AI Team ·
Cohere Acquires Reliant AI to Expand Sovereign Enterprise AI for the Global Biopharma ...
Big AI companies are merging and acquiring each other at record speed. And somehow that's supposed to make your AI decision easier?
If you bought a tool your team never opened, you already know the r
Big AI companies are merging and acquiring each other at record speed. And somehow that's supposed to make your AI decision easier?
If you bought a tool your team never opened, you already know the real problem isn't finding more options. It's knowing which option actually fits your business.
Here's what this week's Cohere-Reliant AI deal quietly confirms: even billion-dollar companies now admit that generic AI fails in specialized industries. They're paying serious money to build AI trained specifically for healthcare and biopharma — because industry-specific beats general-purpose every single time.
That's the insight most consultants won't tell you. The reason that $200/month tool sits unused isn't your team. It's that the tool was built for everyone, which means it was built for no one in your specific situation.
The practical move right now: before evaluating any AI tool, write down the single most repetitive task in your business that eats time but requires no real judgment. That's your pilot. That's where AI earns its first win without touching anything that's already working.
One specific problem. One focused tool. Thirty days to prove it.
What's the one AI tool you've tried that your team quietly stopped using — and what do you think actually killed the adoption?
